Partnership for Health System Sustainability and Resilience (PHSSR)’s Post

Bridging the Gap: Pharma’s Role in Expanding Global Patient Access Pharma companies must prioritize expanding patient reach to address global healthcare disparities. A new report from the Access to Medicine Foundation reveals both progress and gaps in ensuring equitable access to essential medicines, especially in low- and middle-income countries (LMICs). With 19 out of 20 leading pharma companies actively measuring patient reach, the report emphasizes the need for clear, actionable commitments to make a meaningful impact on underserved populations. Collaboration and refined strategies are crucial for achieving true global health equity. #PharmaImpact #GlobalHealthEquity #PatientAccess Link to article-https://lnkd.in/ecfVcXNr

Today, on International Clinical Trials Day, we celebrate the critical role of clinical trials in advancing public health. The #100DaysMission aims to develop diagnostics, therapeutics, and vaccines within 100 days of a pandemic threat. Sustainable, regionally dispersed clinical trial sites are key to achieving this goal. Key Benefits: 📊Speed & Efficiency: Multi-site trials across regions accelerate data collection, helping us meet our 100-day target. 🌐Diverse Representation: Inclusive trials ensure effective treatments for all populations. ⚖ Equitable Access: Regional sites provide low- and middle-income countries access to innovative treatments. 🔬Sustainability: Well-resourced sites maintain high-quality research and preparedness. 🥼Local Capacity Building: Empower regional healthcare systems with advanced research capabilities. By investing in these trial sites, we enhance global health security and ensure that medical breakthroughs benefit everyone everywhere. Let's work together towards a healthier, more prepared world. #InternationalClinicalTrialsDay #GlobalHealth #ClinicalTrials #HealthEquity

📢 Salutem Insights will be presenting at ISPOR Europe 2024 in Barcelona with four impactful sessions covering critical topics in healthcare policy, pricing, and market access. Here’s a look at what we’re sharing: 🔹 Keith Patterson – “The Impact of the Health Act (2013) on the Pricing of Medicines in Ireland” | 18th Nov, 10:30am-1:30pm 🔹 Sandra Redmond & Naoise Ó Flatharta O'Flatharta – “The Price Negotiation Phase of the Reimbursement Process in Ireland” | 18th Nov, 4:00pm-7:00pm 🔹 Sandra Redmond – “Challenges of the PICO Scoping Process: How Does the Number of Involved Member States Impact Results?” | 19th Nov, 4:00pm-7:00pm 🔹 Raymond Henderson – “The Oncology and Allied Digital Health Landscape on the Island of Ireland: Implications for Policy and Practice” | 20th Nov, 9:00am-11:30am 🔎 Scan the QR codes for more details. We’re looking forward to connecting with industry colleagues, sharing our research, and driving meaningful discussions to advance health economics and market access. If you’ll be at ISPOR, drop by we would love to see you. #SalutemInsights #ISPOREurope #HealthcarePolicy #MarketAccess #HealthEconomics #OncologyResearch #DigitalHealth #Barcelona2024 #Pharma

Today is #WorldHealthDay and we join the global community to raise awareness that access to quality healthcare is a right of everyone, regardless of where people live. In low- and middle-income countries, challenges to quality healthcare are becoming increasingly more complex requiring new models and mindsets to break silos to create partnerships that can drive sustainable change. I’m proud of the progress that our Global Health Unit has made in the past two years, helping to address access disparities and strengthen healthcare ecosystems in countries with the highest unmet medical needs. We have achieved this through cross-sector partnerships on a global, national and local level. A snapshot of our progress and impact over the past two years includes: - over 6,000 community health workers and HCPs received training, - more than 360,000 patients have been reached, and -over 40 active or completed programs in over 22 countries. We are continuing to build momentum to address the healthcare inequalities that continue to persist. Discover how we are working together to create sustainable change in some of the most vulnerable communities: https://lnkd.in/eWY66FiW #WorldHealthDay #PublicPrivatePartnerships #globalhealth

Only 4% of all healthcare research and development is focused on female-specific conditions. This staggering statistic was highlighted by Juan Camilo Arjona Ferreira, M.D., Organon Head of Research & Development and Chief Medical Officer, during a health equity panel at Reuters Pharma 2024 (#REpharma2024). During this session, “Secure Faster, Equitable and Broader Global Access,” healthcare leaders discussed the women’s health gap and the importance of an ecosystem approach where, together, we: 👂 Listen to women and consider race, ethnicity and social drivers of health to improve outcomes while reducing inequities  👩 Increase access to diagnostics and solutions to help all women sooner  🤝 📈 Collaborate across the healthcare ecosystem to speed up innovation  Thank you to Jayasree Iyer, CEO, Access to Medicine Foundation for moderating this timely panel and the thought leaders who contributed in a robust discussion: Harmony P. Garges, CMO, ViiV Healthcare and Nicholas Brooke, Executive Director, Patient Focused Medicines Development (PFMD). #WomensHealth #GenderEquality

🌟 𝑻𝒉𝒆 𝑻𝒓𝒂𝒏𝒔𝒇𝒐𝒓𝒎𝒂𝒕𝒊𝒗𝒆 𝑷𝒐𝒕𝒆𝒏𝒕𝒊𝒂𝒍 𝒐𝒇 𝑷𝒖𝒃𝒍𝒊𝒄-𝑷𝒓𝒊𝒗𝒂𝒕𝒆 𝑷𝒂𝒓𝒕𝒏𝒆𝒓𝒔𝒉𝒊𝒑𝒔 𝒊𝒏 𝑯𝒆𝒂𝒍𝒕𝒉𝒄𝒂𝒓𝒆 Dive into the realm of healthcare innovation with this insightful video from the Novartis Foundation, highlighting the transformative power of collaborative efforts. ⚕ Addressing the most essential Social, Economic, Environmental, and Behavioral determinants of cardiovascular disease is critical in tackling the world’s most pressing health challenges: cardiovascular disease and health inequity. 💡 Public-Private Partnerships and AI Applications are reshaping the future of healthcare catalyzing the paradigm shift from today's reactive Healthcare Systems to tomorrow's proactive, predictive and ultimately preventative Health Systems. Watch the video and join the conversation! #CardiovascularDisease #PublicPrivatePartnerships #HealthcareInnovation #NovartisFoundation #AIAapplications #HealthCareSystems.

26% of respondents believe that there’s a rising need for healthspan therapeutics accessibility. Discover the top eight strategies endorsed by 4,000 global citizens to rapidly extend the healthy human lifespan - #Healthspan👇. Our survey showed that 20% of respondents are willing to use longevity-enhancing products or services. It reaches 30% in regions like Brazil and Africa. To boost these numbers and trust in what the science can offer, more research is needed. The Global Healthspan Report reflects insights from policymakers, visionary leaders, health professionals, and citizens across six continents in the hope that it serves as a clarion call for advancing the healthspan agenda for all. Read the report here ➡️  https://lnkd.in/dWV6WsZ5

Just wrapped up some inspiring sessions at Ausbiotech today,and the key themes for staying ahead in our industry couldn’t be more relevant. To drive real impact and bring more clinical trials to Australia, we need to focus on: • Diversity: Leveraging Australia’s diverse population to ensure clinical data is inclusive and representative. • Disease Focus: Targeting areas where Australia excels in recruitment, like infectious disease, to build on our strengths. • Education: Equipping teams and communities with the knowledge to adapt and thrive in an evolving healthcare landscape. • Streamlined Clinical Trials: Tackling healthcare system barriers that impede trials, so breakthroughs reach patients faster. • Teletrials: Enhancing access through teletrials to include patients from outside metro areas, fostering inclusivity and participation. These areas will shape the future of our industry and help us deliver better outcomes for all. #Ausbiotech #HealthcareInnovation #ClinicalTrials #Teletrials #DiversityInHealthcare #EducationInHealth

Join us to explore how we can collectively build a more trustworthy and impactful #health system and elevate the UK #LifeSciences sector. Recent studies in the UK have highlighted public sentiments when it comes to #vaccines and #clinicalresearch. Understanding public concerns about vaccines is crucial, as effective communication and trust-building can help individuals make informed health decisions. Clinical research plays a crucial role in providing #evidence on vaccine safety and efficacy, which reinforces #public #confidence. To enhance vaccine uptake and address hesitancy, collaboration between health authorities and researchers is vital. At this summit, we will address these critical issues through expert panels and insightful discussions aimed at building a more #trustworthy and #effective health system. Panel 1: ➡️ Chair: Professor Azeem Majeed , Imperial College London ➡️ Dr. Andrew Cai, Medical Director, CSL Seqirus ➡️ Dr. Nicola Lang, Director of Public Health, Hammersmith & Fulham Council ➡️ Dr. Philip Cruz, Country Medical Director, Moderna UK ➡️ Phayza Fudlalla, BME Health Forum Panel 2: ➡️ Chair: Dr. Bob Klaber , Imperial College Healthcare NHS Trust ➡️ Dr. Keerti Gedela, EDI Lead, NIHR CRN North West London ➡️ Luke Devey, Chief Medical Officer, Quell Therapeutics ➡️ Naima Adan, Community Engagement Officer, PERC ➡️ Pauline Hakutangwi (She/Her), Patient Engagement Representative, Novartis UK 🎟 Secure your spot: https://lnkd.in/dFjdpjYB #JawdropFireside24 #HealthOutcomes #LifeSciences #TrustInHealthcare #UKHealth #VaccineHesitancy White City Innovation District Hammersmith & Fulham Council Imperial College London Imperial Enterprise Royce at Imperial

All in a day’s work. Living AstraZeneca values. Putting patients first through #collaboration and #partnerships. Our commitment is to promote preventative healthcare , increase access to diagnostics & treatment, and strengthen health systems sustainability and resilience. We aspire to increase accessibility of innovative therapies to diverse patient groups. We are partnering for health system sustainability and resilience. We are doing this through teamwork. https://lnkd.in/dnEjePKc "Teamwork is the ability to work together toward a common vision. The ability to direct individual accomplishments toward organizational objectives. It is the fuel that allows common people to attain uncommon results." – Andrew Carnegie, founder of Carnegie Steel Company. #diseaseprevention #healthsystems #sustainability #resilience #medicine Khomotso Mashilane Ahmed El-Saeed Deepak Arora Neel Andhee-Shah Shelleny Govender-Dhooma (CHRP, M.Inst.Dir) Phumlani Mancapha Reshma Singh Meliska Volschenk Lynne Bisschoff Zaida Abrahams Keshri Vayapuri Govender Edith Matlala-Hlangwane Jacques Scheepers Katlego Sojane, PhD Jane Waithaka Amantha Naicker (Naidoo) Tebogo Tikolo